Figure 2

![Figure 2: Pathological hallmarks of Alzheimer's disease that curcumin may target are illustrated, including amyloid-beta plaques, tau tangles, and neuroinflammation.]()

> Source: Umair Shabbir et al. "Curcumin and Its Derivatives as Theranostic Agents in Alzheimer's Disease: The I." *International journal of molecular sciences*, 2020. PMID: [33375513](https://pubmed.ncbi.nlm.nih.gov/33375513/)

<figure>
  <img src="" alt="Pathological hallmarks of Alzheimer's disease that curcumin may target are illustrated, including amyloid-beta plaques, tau tangles, and neuroinflammation." />
  <figcaption>Figure 2. Pathological hallmarks of Alzheimer's disease that curcumin may target are illustrated, including amyloid-beta plaques, tau tangles, and neuroinflammation.<br>  Source: Umair Shabbir et al. "Curcumin and Its Derivatives as Theranostic Agents in Alzheimer's Disease: The I." <em>International journal of molecular sciences</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/33375513/">33375513</a></figcaption>
</figure>